If you need more lookups,
subscriptions start at $34 USD/month.
Robert Tansley Location
Cambridge, Cambridgeshire, United Kingdom
Robert Tansley Work
2025 -now Chief Medical Officer @
2016 -2025 Board Member @
2025 -now Venture Partner @
2014 -2025 Partner @
2021 -now Board Member @
2024 -now Board Member @
2024 -2025 Executive Chairperson @
2023 -2025 Board Member @
2022 -2025 Board Member @
2017 -2025 Board Member @ Exvastat
2020 -2023 Board Member @ PetMedix (acquired by Zoetis)
2015 -2023 Board Member @ ABCODIA LIMITED (acquired by GENinCODE plc)
2016 -2022 Board Observer @
2016 -2021 Board Member (2016-2019), Board Observer (2019-2021) @
2014 -2021 Board Member @ Inivata (acquired by NeoGenomics)
2015 -2021 Board Member @ MORPHOGEN-IX LIMITED (acquired by Centessa Pharmaceuticals)
2015 -2018 Board Member @
2015 -2018 Board Member @ Congenica (acquired by SeqOne)
now Clinical Team Leader @
2011 -2015 Medical Director @ KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)
now Medical Director @ Arakis Ltd (acquired by SOSEI
2009 -2014 Director @ Tansley & Tansley
2007 -2009 Founder, CEO @ Treague Ltd
2004 -2007 Medical Director @ Arakis Ltd (acquired by SOSEI
2001 -2004 Clinical Team Leader @
now Medical Assessor, Licensing Division @
1999 -2001 Medical Assessor, Licensing Division @
1996 -1999 Medical Advisor @
now Medical Advisor @
now Hospital Medicine @ Clinical appointments at UCH, Westminster and Addenbrooke's Hospital Cambridge
1988 -1996 Hospital Medicine @ Clinical appointments at UCH, Westminster and Addenbrooke's Hospital Cambridge
Robert Tansley Education
University of Cambridge
M.Phil (Epidemiology & Biostatistics)
2004-2005
London Business School
MBA
1998-2000
Faculty of Pharmaceutical Medicine
Diploma of Pharmaceutical Medicine
1996-1998
Royal College of Obstetricians and Gynaecologists
MRCOG
1996-1995
UCL
MBBS (Medicine)
1983-1988
Robert Tansley Skills
Clinical Development
Pharmacovigilance
Regulatory Affairs
Clinical Trials
GCP
New Business Development
Pharmaceutical Industry
Diabetes
Clinical Research
Oncology
Medicine
Pharmacology
Drug Discovery
Biotechnology
FDA
Drug Development
Infectious Diseases
R&D
Pharmaceutics
Lifesciences
Therapeutic Areas
Translational Medicine
IND
Dermatology
Life Sciences
Early-stage Startups
Start-up Ventures
Venture Capital
Investments
Business Development
Good Clinical Practice (GCP)
Research and Development (R&D)
Early Stage Startups
Sales
Good Clinical Practice Gcp
Research And Development R&D
Customer Service
Project Management
Start Up Ventures
Healthcare Management
Capital
Healthcare
Training
Public Speaking
Microsoft Office
Research and Development
Good Clinical Practice
Robert Tansley Summary
Robert Tansley, based in Cambridge, Cambridgeshire, United Kingdom, is currently a Chief Medical Officer at Microbiotica. Robert Tansley brings experience from previous roles at Microbiotica, Cambridge Innovation Capital and Pretzel Therapeutics. Robert Tansley holds a 2004 - 2005 M.Phil in Epidemiology & Biostatistics @ University of Cambridge. With a robust skill set that includes Clinical Development, Pharmacovigilance, Regulatory Affairs, Clinical Trials, GCP and more. Robert Tansley has 5 emails on RocketReach.
Looking for a different Robert Tansley?
Find contact details for 700 million professionals.